Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA methylation meningioma biomarkers: attributes and limitations. | Front Mol Neurosci | 2023 | 37492524 | PubTator, text mining | PubMed |
| Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance. | Commun Biol | 2023 | 37479893 | PubTator, text mining | PubMed |
| Phenotypic and molecular basis of SIX1 variants linked to non-syndromic deafness and atypical branchio-otic syndrome in South Korea. | Sci Rep | 2023 | 37479820 | PubTator, text mining | PubMed |
| Abnormal phase separation of biomacromolecules in human diseases. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37475546 | PubTator, text mining | PubMed |
| Identification of miRNAs in extracellular vesicles as potential diagnostic markers for pediatric epilepsy and drug-resistant epilepsy via bioinformatics analysis. | Front Pediatr | 2023 | 37469680 | PubTator, text mining | PubMed |
| Sequence variations of phase-separating proteins and resources for studying biomolecular condensates. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37464880 | PubTator, text mining | PubMed |
| Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment. | Cancers (Basel) | 2023 | 37444584 | PubTator, text mining | PubMed |
| Emerging Biosensing Methods to Monitor Lung Cancer Biomarkers in Biological Samples: A Comprehensive Review. | Cancers (Basel) | 2023 | 37444523 | PubTator, text mining | PubMed |
| Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022. | Cancers (Basel) | 2023 | 37444402 | PubTator, text mining | PubMed |
| Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer. | Medicine (Baltimore) | 2023 | 37443486 | PubTator, text mining | PubMed |
| Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. | MedComm (2020) | 2023 | 37441462 | PubTator, text mining | PubMed |
| Deciphering the mitophagy receptor network identifies a crucial role for OPTN (optineurin) in acute myeloid leukemia. | Autophagy | 2023 | 37439113 | PubTator, text mining | PubMed |
| The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target. | Cancer Cell Int | 2023 | 37438760 | PubTator, text mining | PubMed |
| Identifying a prognostic model and screening of potential natural compounds for acute myeloid leukemia. | Transl Cancer Res | 2023 | 37434693 | PubTator, text mining | PubMed |
| Translational regulation by uORFs and start codon selection stringency. | Genes Dev | 2023 | 37433636 | PubTator, text mining | PubMed |
| TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2. | Mol Cancer | 2023 | 37430263 | PubTator, text mining | PubMed |
| Bioinformatic analyses reveal the prognostic significance and potential role of ankyrin 3 (ANK3) in kidney renal clear cell carcinoma. | Genomics Inform | 2023 | 37423640 | PubTator, text mining | PubMed |
| Underlying mechanisms and clinical potential of circRNAs in glioblastoma. | Oncol Res | 2023 | 37415736 | PubTator, text mining | PubMed |
| Etiology of super-enhancer reprogramming and activation in cancer. | Epigenetics Chromatin | 2023 | 37415185 | PubTator, text mining | PubMed |
| Genomic characterisation of the overlap of endometriosis with 76 comorbidities identifies pleiotropic and causal mechanisms underlying disease risk. | Hum Genet | 2023 | 37410157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=18